bpc-157 oral vs injectable research BPC #bpc157 #guthealth BPC-157 Injection vs Oral Peptide:
Description
Patent cardinalhealth.com/patents.
Likewise, mothers who are breastfeeding are advised against NAD+ therapy because its unknown if or how NAD+ might pass into breast milk and affect the baby
Though not yet proven, limited evidence suggests an increased cancer risk in those with higher-than-normal B12 levels
K., Weng, T
But it is necessary for proper research
And there's no telling what the next variant will be and if it's going to be more severe or less severe than the ones that are circulating now
